These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 25806648)
1. Persistence with opioid treatment in Germany in patients suffering from chronic non-malignant or cancer pain. Kostev K; Wartenberg F; Richter H; Reinwald M; Heilmaier C Curr Med Res Opin; 2015 Jun; 31(6):1157-63. PubMed ID: 25806648 [TBL] [Abstract][Full Text] [Related]
3. Factors Influencing Long-Term Opioid Use Among Opioid Naive Patients: An Examination of Initial Prescription Characteristics and Pain Etiologies. Shah A; Hayes CJ; Martin BC J Pain; 2017 Nov; 18(11):1374-1383. PubMed ID: 28711636 [TBL] [Abstract][Full Text] [Related]
4. Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: a retrospective cohort study. Gallagher AM; Leighton-Scott J; van Staa TP Clin Ther; 2009 Aug; 31(8):1707-15. PubMed ID: 19808129 [TBL] [Abstract][Full Text] [Related]
6. Trends in chronic opioid use and association with five-year survival in South Korea: a population-based cohort study. Oh TK; Jeon YT; Choi JW Br J Anaesth; 2019 Nov; 123(5):655-663. PubMed ID: 31558315 [TBL] [Abstract][Full Text] [Related]
7. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth]. Noufi P; Khoury E; Ayoub E; Naccache N; Richa S Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797 [TBL] [Abstract][Full Text] [Related]
8. Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain. Ray WA; Chung CP; Murray KT; Hall K; Stein CM JAMA; 2016 Jun; 315(22):2415-23. PubMed ID: 27299617 [TBL] [Abstract][Full Text] [Related]
9. The association between benzodiazepine prescription and aberrant drug-related behaviors in primary care patients receiving opioids for chronic pain. Park TW; Saitz R; Nelson KP; Xuan Z; Liebschutz JM; Lasser KE Subst Abus; 2016; 37(4):516-520. PubMed ID: 27092738 [TBL] [Abstract][Full Text] [Related]
10. Assessment of outcomes following high-dose opioid tapering in a Veterans Healthcare System. Hundley L; Spradley S; Donelenko S J Opioid Manag; 2018; 14(2):89-101. PubMed ID: 29733095 [TBL] [Abstract][Full Text] [Related]
11. The influence of prescription opioid use duration and dose on development of treatment resistant depression. Scherrer JF; Salas J; Sullivan MD; Schneider FD; Bucholz KK; Burroughs T; Copeland L; Ahmedani B; Lustman PJ Prev Med; 2016 Oct; 91():110-116. PubMed ID: 27497660 [TBL] [Abstract][Full Text] [Related]
12. The duration and course of opioid therapy in patients with chronic non-malignant pain. Mellbye A; Karlstad Ø; Skurtveit S; Borchgrevink PC; Fredheim OM Acta Anaesthesiol Scand; 2016 Jan; 60(1):128-37. PubMed ID: 26242816 [TBL] [Abstract][Full Text] [Related]
13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
14. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study. Sittl R; Nuijten M; Nautrup BP Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481 [TBL] [Abstract][Full Text] [Related]
15. Prescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations. Scherrer JF; Salas J; Copeland LA; Stock EM; Ahmedani BK; Sullivan MD; Burroughs T; Schneider FD; Bucholz KK; Lustman PJ Ann Fam Med; 2016; 14(1):54-62. PubMed ID: 26755784 [TBL] [Abstract][Full Text] [Related]
16. US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system. Pergolizzi JV; Ben-Joseph R; Chang CL; Hess G Curr Med Res Opin; 2014 Aug; 30(8):1579-87. PubMed ID: 24689806 [TBL] [Abstract][Full Text] [Related]
17. What Is the Prevalence of Symptomatic Obstructive Sleep Apnea Syndrome in Chronic Spinal Pain Patients? An Assessment of the Correlation of OSAS with Chronic Opioid Therapy, Obesity, and Smoking. Pampati S; Manchikanti L Pain Physician; 2016 May; 19(4):E569-79. PubMed ID: 27228523 [TBL] [Abstract][Full Text] [Related]
18. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients. Radbruch L; Sabatowski R; Petzke F; Brunsch-Radbruch A; Grond S; Lehmann KA Palliat Med; 2001 Jul; 15(4):309-21. PubMed ID: 12054148 [TBL] [Abstract][Full Text] [Related]
19. Opioid therapy in the treatment of chronic pain conditions in Germany. Werber A; Marschall U; L'hoest H; Hauser W; Moradi B; Schiltenwolf M Pain Physician; 2015; 18(3):E323-31. PubMed ID: 26000679 [TBL] [Abstract][Full Text] [Related]
20. Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis. Gore M; Sadosky A; Leslie D; Tai KS; Seleznick M Clin Ther; 2011 Dec; 33(12):1914-31. PubMed ID: 22088416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]